USA

Arcus Biosciences, Inc. (NYSE:RCUS) Just Reported, And Analysts Assigned A US$29.60 Price Target

As you might know, Arcus Biosciences, Inc. (NYSE:RCUS) just kicked off its latest third-quarter results with some very strong numbers. ...

Tether Profit Soars to $10B in 2025

Tether, the issuer of the USDT stablecoin, has released its Q3 2025 financial report, prepared by auditors from BDO. The company revealed that its...

Popular

Subscribe

spot_imgspot_img